Related Experiment Videos
Thrombolytic therapy for acute pulmonary embolism
1Department of Medicine, Center for Pulmonary Vascular Disease, Duke University Medical Center, Durham, North Carolina 27710, USA. tapso001@mc.duke.edu
Seminars in Thrombosis and Hemostasis
|March 30, 2013
Summary
Thrombolytic therapy dissolves acute pulmonary embolism (PE) but carries bleeding risks. Massive PE is the primary indication, while submassive PE remains controversial, necessitating careful patient selection.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Pharmacology
Background:
- Acute pulmonary embolism (PE) is a life-threatening condition.
- Thrombolytic therapy offers rapid clot dissolution but poses bleeding risks.
- Existing guidelines for thrombolysis in PE have evolved, yet questions persist.
Purpose of the Study:
- To critically analyze the application of thrombolytic therapy for acute pulmonary embolism.
- To discuss the evolving landscape of thrombolytic agents and delivery methods.
- To highlight the importance of risk stratification and contraindications.
Main Methods:
- Review of existing literature and guidelines on thrombolytic therapy for PE.
- Analysis of approved and investigational thrombolytic agents.
- Discussion of intravenous versus intraembolic delivery methods.
- Consideration of risk stratification and patient selection.
Main Results:
- Massive PE is the clearest indication for thrombolysis.
- Submassive PE treatment with thrombolysis is more controversial.
- Intraembolic therapy is gaining traction but lacks extensive randomized trials.
- Tissue-type plasminogen activator is widely used due to proven efficacy and short infusion time.
Conclusions:
- Thrombolytic therapy is a critical treatment for acute PE, particularly massive PE.
- Careful risk stratification and consideration of contraindications are essential for safe and effective use.
- Further research, including randomized trials, is needed to clarify optimal use in various PE scenarios.
Related Concept Videos
01:27Pulmonary Embolism III: Nursing Management
209
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
209
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
165
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
165
01:29Pulmonary Embolism I: Introduction
386
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
386
01:29Venous Thrombosis III: Interprofessional Care
193
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
193
01:30Venous Thrombosis I: Introduction
180
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
180
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K